What Do "5x" and "20x" Extract Ratios Really Mean? Lessons from Quantitative Testing of Botanical Extracts

Why Are Botanical Products Labeled "5x, 20x, or 100x"? Crude Input Ratios vs. Active Constituent Potency

When shopping for botanical extracts—whether everyday legal herbs such as blue lotus, damiana, and yerba mate extract powders, or specialized plants examined in forensic chemistry literature—consumers frequently encounter labels stamped with "5x," "10x," "20x," or even "100x." It is natural to assume that a "20x" product delivers 20 times the concentration of active phytochemicals found in natural dried leaves.

In natural product processing, however, these multipliers frequently conflate two fundamentally different concepts:

• Distinguishing Crude Extract Input Ratio (e.g., 10:1): This simply indicates that 10 kg of dried plant material were extracted and concentrated down to 1 kg of solid extract (or that a crude extract from 9 parts leaf was sprayed onto 1 part dried leaf to produce "fortified leaves"). It reflects raw material weight reduction, not active compound survival. If the starting material had low phytochemical levels, if the wrong solvent polarity was chosen, or if heat degraded the molecules during evaporation, the final product may contain very little of the target compound.
• Understanding Standardized Quantitative Extracts: A true standardized extract is assayed via high-performance liquid chromatography (HPLC) or mass spectrometry (MS) to guarantee a verified weight of a specific marker compound (e.g., milligrams or micrograms per gram of product).

How wide is the gap between a printed "x" multiplier and actual laboratory measurements when products lack standardization? Multi-country analytical studies provide a striking answer.

Labeled "100x" Yet Weaker Than Raw Leaf? Laboratory Comparison of Commercial Extracts

To test whether commercial "high-potency" labels match chemical reality, pharmaceutical and forensic toxicology teams in Taiwan, the United States, Japan, and Europe analyzed one of the most heavily marketed "x-factor" botanicals in analytical literature: Salvia divinorum (whose primary marker diterpenoid is salvinorin A; note: Salvia divinorum and salvinorin A are strictly controlled Schedule III substances in Taiwan and regulated in many jurisdictions worldwide—these studies are cited solely to illustrate analytical principles of botanical extract quantification).

Data from Kaohsiung Medical University and Taipei Medical University published in the Journal of Food and Drug Analysis (Lin et al., 2014), alongside investigations from Florida (Wolowich et al., 2006) and a comprehensive review by researchers at the University of Porto (Brito-da-Costa et al., 2021), reveal a dramatic disconnect between label claims and measured concentrations:

Research Group & Source	Tested Sample & Labeled Multiplier	Measured Salvinorin A (per 100 mg sample)	True Comparison Against Natural Dried Leaf	Detected Anomalies or Adulterants
Lin et al. (2014) (Kaohsiung & Taipei Medical Universities)	Commercial Natural Dried Leaves (1x)	84.10 ± 3.06 μg (~0.84 mg/g)	Consistent with published natural leaf baselines (63–370 μg / 100 mg).	None (baseline reference).
Lin et al. (2014) (Kaohsiung & Taipei Medical Universities)	Labeled "30fx" Concentrated Extract (Source: Taiwan)	163.97 ± 6.48 μg (~1.64 mg/g)	Only 1.95× the concentration of the tested raw leaves—far below the claimed 30×.	Severe potency inflation on label.
Lin et al. (2014) (Kaohsiung & Taipei Medical Universities)	Labeled "100fx" Concentrated Extract (Source: Canada)	55.75 ± 1.73 μg (~0.56 mg/g)	Only 0.66× the raw leaf baseline—a "100x" extract actually contained 34% less active compound than plain dried leaves.	Multiplier label completely disconnected from chemical content.
Wolowich et al. (2006) (Nova Southeastern University, USA)	5 commercial products labeled "5x to 20x"	12.6–113.7 μg (~0.126–1.137 mg/g)	Measured potency was only 4% to 41% of label claims; several extracts were weaker than average raw leaf.	3 of 5 products contained undeclared adulterants: 2 contained vitamin E and 1 contained caffeine.
Tsujikawa et al. (2008) (cited in Brito-da-Costa et al., 2021)	Products sold in Japan labeled "2x to 25x"	410–3,890 μg (~4.1–38.9 mg/g)	Higher than raw leaf, but labeled multipliers showed no consistent correlation with actual content across brands.	Nearly 10-fold variation across commercial batches.

Why Do Some "High-Ratio" Extracts Contain So Little Active Compound? 4 Scientific Variables

Why does concentrating a plant so often fail to yield a proportionally concentrated product? Experimental optimization data from Lin et al. (2014) and phytochemical findings reviewed by Brito-da-Costa et al. (2021) point to four decisive factors:

• Wide Natural Variation Across Plant Parts and Harvest Batches (Nearly 9-Fold): Secondary metabolites are rarely distributed evenly throughout a plant. As summarized by Brito-da-Costa et al. (2021), salvinorin A is synthesized and stored specifically in abaxial glandular trichomes on the underside of leaves, while roots, internal stem tissues, cotyledons, and corollas contain none. Even among genetically identical clones, leaf freshness, altitude, and cultivation conditions cause natural leaf concentrations to fluctuate between 0.89 mg/g and 7.8 mg/g. Concentrating stems or low-potency leaves 10-fold still yields a weak extract.
• The "Same Genus" Misconception: Buyers sometimes assume that related species within the same botanical genus share identical active compounds. Lin et al. (2014) tested eight Salvia species endemic to Taiwan (S. arisanensis, S. coccinea, S. hayatana, S. japonica, S. nipponica var. formosana, S. scapiformis, S. tashiroi, and S. keitaoensis) under identical HPLC conditions and found zero salvinorin A in any of the eight species, underscoring that secondary metabolites are highly species-specific.
• Solvent Polarity Mismatch (Water vs. Alcohol vs. Lipophilic Compounds): Every phytochemical has a specific polarity profile (salvinorin A, for instance, is a highly lipophilic non-nitrogenous diterpenoid with $\log P = 2.5$ and very poor water solubility). When Lin et al. (2014) compared four extraction solvents—methanol, ethanol, acetonitrile, and ethyl acetate—methanol achieved significantly higher extraction efficiency than ethanol, acetonitrile, or ethyl acetate. If a manufacturer uses hot water to produce a "20x extract powder" of a herb whose key compounds are lipophilic, the active molecules remain in the discarded plant marc while water-soluble sugars and gums make up the bulk weight.
• Steeping Duration and Thermal Degradation (Longer Is Not Always Better): Extracting longer does not perpetually increase yield. In the 1-to-5-day time-course experiment by Lin et al. (2014), extracted salvinorin A peaked at 3 days of steeping, whereas extending steeping to 4 or 5 days caused a marked drop in concentration due to compound degradation in the crude extract; similarly, sonication beyond 2 minutes raised temperatures and reduced stability.

Evidence Boundaries, Legal Compliance, and Smart Herbal Sourcing

• Respect Legal Boundaries Between Forensic Case Studies and Everyday Herbs: The Salvia divinorum studies cited above serve strictly as an analytical chemistry case study on extract labeling and degradation. Salvia divinorum and salvinorin A are controlled substances in Taiwan (Schedule III since July 2022) and prohibited or restricted in Australia, Japan, South Korea, Germany, Italy, Denmark, and numerous US states (Lin et al., 2014; Brito-da-Costa et al., 2021). Consumers should never purchase or possess regulated substances.
• Apply Label Literacy to Legal Culinary and Wellness Botanicals: The exact same extraction principles apply to everyday legal herbs (such as yerba mate, blue lotus, damiana, and mulungu). Whenever a product advertises "10x" or "20x," ask whether that figure represents an unverified crude input ratio or an HPLC-standardized marker percentage, what solvent was used, and whether carriers or synthetic additives were blended in.
• Recognize Why Whole Dried Leaves Often Offer Greater Transparency: Unlike opaque powders or sprayed extracts—which laboratory testing shows are vulnerable to thermal degradation and adulteration with compounds like caffeine or vitamin E (Wolowich et al., 2006)—intact dried leaves allow direct morphological and microscopic verification of plant identity and freshness.

Frequently Asked Questions (FAQ)

Q1: What does "10x" or "20x" usually mean on a commercial herbal extract label?

On unstandardized herbal products, "10x" or "20x" typically refers only to the crude input weight ratio (e.g., 10 or 20 parts raw plant reduced to 1 part finished weight), not a guaranteed 10- or 20-fold increase in active phytochemicals. Laboratory analyses by Lin et al. (2014) and Wolowich et al. (2006) showed that some products labeled up to "100fx" actually contained less active marker compound than ordinary dried leaves.

Q2: Why can a "concentrated" herbal extract contain fewer active compounds than raw leaves?

Three technical factors explain this paradox: (1) starting with low-potency plant parts such as stems or aged leaves (natural leaf levels alone vary nearly 9-fold); (2) using an incompatible solvent polarity (such as water for lipophilic terpenoids or aglycones); and (3) hydrolytic or thermal degradation during prolonged steeping (beyond 3 days) or heat evaporation (Lin et et al., 2014).

Q3: What undeclared adulterants have been found in commercial concentrated herbal extracts?

In GC-MS and HPLC testing of five commercial "5x–20x" extracts, Wolowich et al. (2006) detected undeclared adulterants in three products—specifically caffeine in one sample and vitamin E in two samples—highlighting the higher adulteration risk of processed extracts compared with whole botanicals.

Q4: Do native Taiwanese Salvia species contain salvinorin A?

No. When researchers at Kaohsiung Medical University and Taipei Medical University (Lin et al., 2014) analyzed eight endemic Taiwanese Salvia species (S. arisanensis, S. coccinea, S. hayatana, S. japonica, S. nipponica var. formosana, S. scapiformis, S. tashiroi, and S. keitaoensis) by HPLC, salvinorin A was completely absent in all eight species.

References & Primary Sources

1. Lin, P.-X., Li, J.-H., Chen, S.-H., Chang, H.-C., & McKetin, R. (2014). Quantitative determination of salvinorin A, a natural hallucinogen with abuse liability, in Internet-available Salvia divinorum and endemic species of Salvia in Taiwan. Journal of Food and Drug Analysis, 22(3), 370–378. DOI: 10.1016/j.jfda.2014.01.017 (PMC Full Text )
2. Brito-da-Costa, A. M., Dias-da-Silva, D., Gomes, N. G. M., Dinis-Oliveira, R. J., & Madureira-Carvalho, Á. (2021). Pharmacokinetics and Pharmacodynamics of Salvinorin A and Salvia divinorum: Clinical and Forensic Aspects. Pharmaceuticals, 14(2), 116. DOI: 10.3390/ph14020116 (PMC Full Text | PubMed )
3. Wolowich, W. R., Perkins, A. M., & Cienki, J. J. (2006). Analysis of the psychoactive terpenoid salvinorin A content in five Salvia divinorum herbal products. Pharmacotherapy, 26(9), 1268–1272. DOI: 10.1592/phco.26.9.1268 (PubMed)